(19 days)
Not Found
No
The document describes a standard vital signs monitor and does not mention any AI or ML capabilities.
No.
The device is a monitor that displays vital signs, which is a diagnostic function, not a therapeutic one.
Yes
The device monitors multiple vital signs (ECG, respiration, blood pressure, temperature, CO2, SpO2) and displays them in real-time, which are used by clinicians to assess a patient's health status, thus aiding in diagnosis.
No
The device description explicitly states it is a "multi-parameter patient monitor equipped with either a monochrome or color display" and is "Rechargeable batteries power the monitors," indicating it is a hardware device with integrated software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
- Device Function: The Propaq 200 Series monitors are described as monitoring vital signs (ECG, respiration, blood pressure, temperature, CO2, SpO2) directly from the patient. This is in vivo monitoring, not in vitro testing of specimens.
- Intended Use: The intended use clearly states "multiparameter vital signs monitoring of neonatal, pediatric, and adult patients." This aligns with patient monitoring, not laboratory testing of samples.
The device is a patient monitor used for real-time physiological measurements, which falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
The Propaq 200 Series monitors are intended to be used by skilled clinicians for multiparameter vital signs monitoring of neonatal, pediatric, and adult patients in health care facility bedside applications; as well as for intrafacility and interfacility transport.
Product codes (comma separated list FDA assigned to the subject device)
74 DRT
Device Description
The Propaq 200 Series monitors are small, light weight, portable, multi-parameter patient monitors equipped with either a monochrome or color display. The monitors provide real time monitoring and display of ECG, respiration, invasive blood pressure, noninvasive blood pressure, temperature, CO2 and SpO22. Rechargeable batteries power the monitors. The Propaq 200 Series monitors can communicate with Welch Allyn Protocol's Acuity® central station through a local area network. The communication link is bi-directional, ventral station and one a louity central station and remote control of the Propaq from the Acuity central station.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
neonatal, pediatric, and adult
Intended User / Care Setting
skilled clinicians; health care facility bedside applications; intrafacility and interfacility transport.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Propaq 200 Series monitors and associated accessories have been tested and found to comply with the recognized national and international, performance, safety, and electromagnetic compatibility standards for medical devices and product specifications listed in the Propaq labeling.
A risk analysis, identifying potential hazards and documenting mitigation of the hazards, has been developed and verified/validated as part of Welch Allyn Protocol's product development procedures.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K945071, K951246, K951246, K993637
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
AUG 2 0 2001
Koi 2451 p.1/2
510(k) Summary of Safety and Effectiveness
July 31, 2001
Submitter
Welch Allyn Protocol, Inc. 8500 S.W. Creekside Place Beaverton, OR 97008-7107 USA
Telephone: (503) 526-8500 Fax: (503) 526-4200
Contact: Mr. Donald M. Abbey, Vice President, Quality Systems
Device Name
Trade Name: Propaq 200 Series Monitors Common Name: Cardiac Monitor Common Name: Cardiac Monitor (Reference, 21CFR870.2300, April 1, 1999). The Propaq Monitors also contains a Pulse Oximetry (SpO2) channel (Reference, 21CFR870.2700, April 1, 1999).
Classification: Class II
Predicate Device
The predicate device for the Propaq 200 Series Monitors is the Propaq 200 Series cleared for market under 510(k) submissions K945071 and K951246, except for the improved SpO2 Channel. The predicate device for the improved SpO2 Channel in the Propaq 200 Series is the Nellcor model N-395 Pulse Oximeter cleared for market under 510(k) submissions K951246 and K993637.
Device Description
The Propaq 200 Series monitors are small, light weight, portable, multi-parameter patient monitors equipped with either a monochrome or color display. The monitors provide real time monitoring and display of ECG, respiration, invasive blood pressure, noninvasive blood pressure, temperature, CO2 and SpO22. Rechargeable batteries power the monitors. The Propaq 200 Series monitors can communicate with Welch Allyn Protocol's Acuity® central station through a local area network. The communication link is bi-directional, ventral station and one a louity central station and remote control of the Propaq from the Acuity central station.
Indications for Use
The Propaq 200 Series monitors are intended to be used by skilled clinicians for multiparameter vital signs monitoring of neonatal, pediatric, and adult patients in health care facility bedside applications; as well as for intrafacility and interfacility transport.
1
K012451 p. 2/2
Technological Comparison to the Predicate Device
The Protocol 200 Series monitor is the same as the Propaq 200 Series Monitors cleared for market under 510(k) submission numbers K945071 and K951246. The improved SpO2 channel in the Propaq 200 Series is a replacement for the SpO2 channel currently in the Propaq 200 Series monitors. Nellcor Puritan Bennett manufactures the SpO2 Channel currently in the Propaq 200 series. The improved SpO2 channel is also manufactured Nellcor Puritan Bennett. The improved SpO2 channel is substantially equivalent to the SpO2 channel in the Nellcor model N-395 Pulse Oximeter. The Nellcor model N-395 was cleared for market under 510(k) submissions K991823 and K993637.
Summary of Performance Testing
The Propaq 200 Series monitors and associated accessories have been tested and found to comply with the recognized national and international, performance, safety, and electromagnetic compatibility standards for medical devices and product specifications listed in the Propaq labeling.
A risk analysis, identifying potential hazards and documenting mitigation of the hazards, has been developed and verified/validated as part of Welch Allyn Protocol's product development procedures. Welch Allyn Protocol's Quality System conforms to 21CFR820 and is certified by TUV Product Service to ISO 9001 and EN46001.
Conclusions
As stated above, Protocol's conclusion is that the Propaq 200 Series monitors are safe, effective, comply with the appropriate medical device standards, and equivalent to the Propaq 200 series currently on the market.
This 510(k) Summary of Safety and Effectiveness may be copied and submitted to interested parties as required by 21CFR807.92.
2
Image /page/2/Picture/1 description: The image contains the words "Public Health Service" in a simple, bold font. The text is arranged on a single line. The words are in black and the background is white.
Image /page/2/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three curved lines representing its wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
AUG 2 0 2001
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Donald M. Abbey Vice President, Quality System Welch Allyn Protocol, Inc. 8500 S.W. Creekside Place Beaverton, OR 97008-7107
Re: K012451
Trade Name: Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246 Regulation Number: 21 CFR 870.2300 Regulatory Class: II (two) Product Code: 74 DRT Dated: July 31, 2001 Received: August 1, 2001
Dear Mr. Abbey:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general control provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning vour device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Mr. Donald M. Abbey
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4645. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Dale Millh
James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
Applicant: Welch Allyn Protocol. Inc. Beaverton, OR 97008-7107 USA
Telephone: (503) 526-8500 Fax: (503) 526-4245
Kol2451 510(k) Number: _
Device Name: Propaq 200 Series Monitors
Indications for Use:
Indications for USE.
The Propaq 200 Series monitors are intended to be used by skilled continutions and wall as THE Fropaq 200 Scries moliners are meensed in health care facility bedside applications; as well as for intrafacility and interfacility transport.
(Please do not write below this line - continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
OR Over-The Counter __
Ram W
on of Cardiovascular & Respiratory De
Number: K045
21